Mr. Silvestro was appointed to the Company's Board in June 2025. Mr. Silvestro joined the Company as Chief Commercial Officer in April 2019, and was promoted to President in October 2023. Mr. Silvestro was appointed Interim CEO in January 2025 and appointed CEO in March 2025. Prior to joining the Company, from January 2018 to April 2019, Mr. Silvestro was Vice President and General Manager of Tagetik North America LLC (dba CCH Tagetik), a Wolters Kluwer company, that provides corporate performance management software solutions for planning, consolidation and reporting. From April 2017 to January 2018, Mr. Silvestro was the Chief Commercial Officer of Prognos Health, Inc., a healthcare data and analytics company, and from September 2007 to April 2017, he was with Decision Resources Group, a multi-national corporation that provides high value global data solutions, analytics and consulting services to pharmaceutical, biotech, medical device, healthcare provider and payer, and managed care companies, in various capacities with him last serving as Executive Vice President, Head of Global Sales. Mr. Silvestro is qualified to serve on our Board because of his extensive leadership expertise within the Company and the healthcare industry.